Nicholas Company, Inc. Charles River Laboratories International, Inc. Transaction History
Nicholas Company, Inc.
- $5.51 Billion
- Q1 2025
A detailed history of Nicholas Company, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Nicholas Company, Inc. holds 69,446 shares of CRL stock, worth $10.2 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
69,446
Previous 69,446
-0.0%
Holding current value
$10.2 Million
Previous $12.8 Million
18.46%
% of portfolio
0.19%
Previous 0.22%
Shares
15 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$900 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$750 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$632 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$353 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$288 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.5B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...